ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $193,285 | +340.9% | 87,065 | +432.3% | 0.00% | – |
Q1 2024 | $43,834 | -36.7% | 16,356 | -29.4% | 0.00% | – |
Q4 2023 | $69,296 | +214.3% | 23,176 | +3.0% | 0.00% | – |
Q3 2023 | $22,045 | -38.9% | 22,495 | -13.3% | 0.00% | – |
Q2 2023 | $36,069 | -24.9% | 25,949 | -14.1% | 0.00% | – |
Q1 2023 | $48,040 | -73.0% | 30,214 | +5.6% | 0.00% | – |
Q4 2022 | $178,240 | -94.6% | 28,610 | -94.2% | 0.00% | -100.0% |
Q3 2022 | $3,327,000 | +2276.4% | 496,516 | +2166.6% | 0.00% | – |
Q2 2022 | $140,000 | +115.4% | 21,906 | +55.3% | 0.00% | – |
Q1 2022 | $65,000 | -57.5% | 14,105 | +11.4% | 0.00% | – |
Q3 2021 | $153,000 | -32.0% | 12,667 | +19.2% | 0.00% | – |
Q2 2021 | $225,000 | -93.6% | 10,630 | -90.5% | 0.00% | -100.0% |
Q1 2020 | $3,523,000 | +1140.5% | 111,725 | +2243.2% | 0.00% | – |
Q4 2019 | $284,000 | -95.4% | 4,768 | -96.4% | 0.00% | -100.0% |
Q2 2019 | $6,145,000 | +2398.0% | 132,085 | +2056.1% | 0.00% | – |
Q1 2019 | $246,000 | -95.3% | 6,126 | -95.5% | 0.00% | -100.0% |
Q2 2018 | $5,284,000 | -27.4% | 134,821 | +34.0% | 0.00% | -33.3% |
Q1 2018 | $7,275,000 | +3.2% | 100,582 | -6.1% | 0.00% | 0.0% |
Q4 2017 | $7,051,000 | -19.2% | 107,099 | -38.5% | 0.00% | 0.0% |
Q3 2017 | $8,726,000 | -35.6% | 174,097 | -40.6% | 0.00% | -25.0% |
Q2 2017 | $13,556,000 | +4690.1% | 292,917 | +3552.3% | 0.00% | – |
Q1 2017 | $283,000 | -88.4% | 8,020 | -95.4% | 0.00% | -100.0% |
Q3 2016 | $2,440,000 | +40.1% | 176,197 | -0.0% | 0.00% | 0.0% |
Q2 2016 | $1,742,000 | -54.9% | 176,229 | -22.9% | 0.00% | -50.0% |
Q1 2016 | $3,864,000 | +38.3% | 228,501 | +82.1% | 0.00% | +100.0% |
Q4 2015 | $2,793,000 | -3.2% | 125,478 | +2.6% | 0.00% | 0.0% |
Q3 2015 | $2,886,000 | -67.1% | 122,337 | +13.9% | 0.00% | -66.7% |
Q2 2015 | $8,779,000 | -15.7% | 107,368 | -4.5% | 0.00% | -25.0% |
Q1 2015 | $10,411,000 | +783.0% | 112,435 | +285.8% | 0.00% | – |
Q4 2014 | $1,179,000 | – | 29,145 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
EMC Capital Management | 27,566 | $246,000 | 0.14% |
PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |